{
    "2021-05-13": [
        [
            {
                "time": "",
                "original_text": "云南白药豪掷千金联姻上海医药（02607），能否实现双赢？",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "投资",
                        "联姻"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药投资百亿，成为上海医药第二大股东",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "投资",
                        "第二大股东"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "炒股失利，云南白药又拿百亿投资上药，百年老店“短板”待破解",
                "features": {
                    "keywords": [
                        "云南白药",
                        "炒股失利",
                        "投资",
                        "上海医药",
                        "短板"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "涨停复盘 | 沪指跌近1% 多只中药股逆势封涨停",
                "features": {
                    "keywords": [
                        "涨停",
                        "中药股",
                        "逆势",
                        "沪指"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2020董秘薪酬报告：最高达千万元，差距达百倍",
                "features": {
                    "keywords": [
                        "董秘",
                        "薪酬",
                        "差距"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "7部门发文支持大力发展中医药服务贸易，中药板块领涨两市丨牛熊眼",
                "features": {
                    "keywords": [
                        "中医药",
                        "政策支持",
                        "服务贸易",
                        "中药板块",
                        "领涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "什么情况？A股中药罕见集体爆发，有股直线拉20%",
                "features": {
                    "keywords": [
                        "A股",
                        "中药",
                        "集体爆发",
                        "直线拉升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "云南白药回应年报“议论”：有疑问可以理解",
                "features": {
                    "keywords": [
                        "云南白药",
                        "年报",
                        "议论"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "粤开知更荟 | 音频解读●4月金融数据公布，云南白药拟为上海医药第二大股东",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "第二大股东",
                        "金融数据"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药拟定增募资144亿，云南白药斥资112亿入股！强强联合背",
                "features": {
                    "keywords": [
                        "上海医药",
                        "定增",
                        "募资",
                        "云南白药",
                        "入股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药百亿战投上海医药 前者去年超26亿利润靠炒股实现",
                "features": {
                    "keywords": [
                        "云南白药",
                        "上海医药",
                        "战投",
                        "炒股",
                        "利润"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}